| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biochemistry and Biophysics |
Division of Molecular Biology, Department of Surgery, Medical Faculty Charité, Humboldt University [C. P., X. H., J. M., D. B-O., W. D.], and Department of Molecular Biology, Max-Planck-Institute of Infection Biology [M. N.], 10117 Berlin, Germany
Angiogenesis is a prerequisite for solid tumor growth and metastasis. Elucidation of the signaling pathways that control tumor angiogenesis constitutes the basis for a rational antiangiogenic tumor therapy. Here we show that the production of vascular endothelial growth factor (VEGF) in HeLa and HL-60 cells is directed by the constitutive photomorphogenesis 9 signalosome (CSN). The CSN is a kinase complex that cooperates with the ubiquitin/26S proteasome system in regulating the stability of proteins involved in signal transduction. VEGF expression is controlled by the transcription factors activator protein (AP)-1, AP-2, SP-1, and hypoxia-inducible factor 1. Inhibition of CSN kinase activity by 50 µM curcumin for 2 h decreases the cellular c-Jun concentration, resulting in a reduction of the VEGF production by approximately 75%. The removal of the inhibitor from the cells led to a time-dependent recovery of endogenous c-Jun that is paralleled by increasing VEGF production. Elevated cellular CSN activity induced by CSN subunit 2 overexpression causes increased VEGF production in HeLa cells. A competitor of CSN-dependent c-Jun phosphorylation, the NH2-terminal c-Jun fragment
c-Jun(1226), inhibits VEGF production in HeLa cells. The transcription factors AP-2 and SP-1 act independently of the CSN. They contribute less than a quarter to basal VEGF production. Under our experimental conditions, hypoxia-inducible factor 1
protein was not detected. Overexpression of the tumor suppressor p53 reduces VEGF production in HeLa cells. p53 competes with c-Jun for CSN-specific phosphorylation with the consequence of c-Jun destabilization. We conclude that CSN-directed c-Jun signaling mediates high VEGF production in HeLa and HL-60 cells. The data provide an explanation for the known antiangiogenic and antitumorigenic activities of curcumin. Because the CSN regulates the major part of VEGF production in the tested tumor cells, it constitutes a potentially important target for tumor therapy.
This article has been cited by other articles:
![]() |
J. F. Lima, I. Malavazi, M. R. von Zeska Kress Fagundes, M. Savoldi, M. H. S. Goldman, E. Schwier, G. H. Braus, and G. H. Goldman The csnD/csnE Signalosome Genes Are Involved in the Aspergillus nidulans DNA Damage Response Genetics, November 1, 2005; 171(3): 1003 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wu, S. Brandt, and S. M. Hyder Ligand- and Cell-Specific Effects of Signal Transduction Pathway Inhibitors on Progestin-Induced Vascular Endothelial Growth Factor Levels in Human Breast Cancer Cells Mol. Endocrinol., February 1, 2005; 19(2): 312 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Bai, F. Cerimele, M. Ushio-Fukai, M. Waqas, P. M. Campbell, B. Govindarajan, C. J. Der, T. Battle, D. A. Frank, K. Ye, et al. Honokiol, a Small Molecular Weight Natural Product, Inhibits Angiogenesis in Vitro and Tumor Growth in Vivo J. Biol. Chem., September 12, 2003; 278(37): 35501 - 35507. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Emberley, Y. Niu, E. Leygue, L. Tomes, R. D. Gietz, L. C. Murphy, and P. H. Watson Psoriasin Interacts with Jab1 and Influences Breast Cancer Progression Cancer Res., April 15, 2003; 63(8): 1954 - 1961. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gukovsky, C. N. Reyes, E. C. Vaquero, A. S. Gukovskaya, and S. J. Pandol Curcumin ameliorates ethanol and nonethanol experimental pancreatitis Am J Physiol Gastrointest Liver Physiol, January 1, 2003; 284(1): G85 - G95. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sun, M. P. Wilson, and P. W. Majerus Inositol 1,3,4-Trisphosphate 5/6-Kinase Associates with the COP9 Signalosome by Binding to CSN1 J. Biol. Chem., November 22, 2002; 277(48): 45759 - 45764. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hannenhalli and S. Levy Predicting transcription factor synergism Nucleic Acids Res., October 1, 2002; 30(19): 4278 - 4284. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bech-Otschir, M. Seeger, and W. Dubiel The COP9 signalosome: at the interface between signal transduction and ubiquitin-dependent proteolysis J. Cell Sci., January 2, 2002; 115(3): 467 - 473. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |